3 US Stocks For Defensive Dividends And Balance Sheet Questions

With U.K. GDP slipping 0.1% in April 2026, services activity under pressure, and energy costs surging on the back of the U.S.-Iran war, many investors are rethinking how much risk they want to carry. Defensive dividend stocks, particularly those with stronger balance sheets and a track record of steady payouts, can appeal to anyone who prefers reliability when growth and inflation worries collide. This article walks through three stocks from a Defensive Dividend Stocks screener that appear closely tied to these macro trends and explains how the latest data could influence the way you think about each one.

Overview: Atmos Energy is a regulated U.S. natural gas utility that distributes gas to about 3.4 million homes, businesses, and public customers across eight states, supported by a large network of underground pipes and storage facilities.

Operations: Atmos Energy generates about US$4.6b from its Distribution segment and US$1.1b from Pipeline and Storage, all from customers in the United States.

Market Cap: US$28.4b

Investors looking at Atmos Energy in the current energy shock may find an interesting mix of resilience and pressure. On one hand, its regulated gas network, long record of dividend growth, and ongoing capital program aimed at safety and reliability give it a profile that often appeals when inflation and fuel costs are unsettled. At the same time, weak free cash flow coverage of the dividend, heavy reliance on external debt funding, and lawsuits related to gas incidents raise questions about how robust that stability really is. The valuation suggests the market already rates the business highly. The key issue is whether the earnings, regulation, and balance sheet can support that view over time.

Atmos Energy’s regulated earnings and dividend record could be masking a more complicated funding story, so before assuming the stability is unshakeable, review the 3 key rewards and 2 important warning signs (1 is major!)

Overview: Convatec Group develops and sells medical products for chronic conditions, including advanced wound dressings, ostomy bags, continence care solutions, and infusion sets used in treatments like diabetes and Parkinson’s disease. It supplies hospitals, pharmacies, and healthcare providers globally.

Operations: Convatec Group generates about $2.4b in revenue from the development, manufacture, and sale of medical products and technologies, with key markets including the US, Denmark, the UK, and other international regions.

Market Cap: £4.0b

Convatec Group stands out in a weaker U.K. economy because demand for its wound, ostomy, continence, and infusion products is tied to chronic conditions rather than consumer confidence. Analysts currently see scope for faster earnings and revenue growth than the broader market. At the same time, the company carries high debt and faces meaningful U.S. reimbursement risk affecting up to 12% of group revenue. It has also been dealing with large one off items that cloud recent profit trends. For investors interested in how new product launches, margin improvement efforts, and analyst expectations balance against those funding and policy pressures, Convatec Group offers a detailed case study in what a defensive healthcare stock can and cannot absorb when growth slows and inflation stays sticky.

Convatec Group’s earnings story, chronic care focus, and high debt raise important questions about how much cushion really sits behind the share price, so go through the 3 key rewards and 3 important warning signs

Overview: Genie Energy is an energy services company that supplies electricity and natural gas to residential and small business customers in deregulated U.S. markets, while also developing and operating utility scale solar projects. It supplements this with solar panel distribution, advisory services for larger customers, and marketing of other energy related products.

Operations: Genie Energy generates about $480.7m from its core Genie Retail Energy segment and $26.7m from Genie Renewables.

Market Cap: $369.1m

Genie Energy sits at an interesting crossroads for readers looking at defensive dividend stocks tied to the energy supply chain. The core retail business generates most of its $500m class revenue, while Genie Renewables and advisory services give exposure to trends in electrification and distributed solar. At the same time, margins have come under pressure, with net income and EPS both lower in 2025 and Q1 2026, and recent filing delays plus NYSE compliance issues add a layer of governance and execution risk. If you are weighing a company that mixes recurring utility style cash flows with renewables growth ambitions and a modest dividend, the key question is how comfortable you are with the trade off between that income profile and the operational, regulatory, and reporting risks sitting beside it.

Genie Energy’s mix of recurring utility cash flows and solar growth plans could be hiding a far more interesting balance of income and risk than it first appears, so walk through the 2 key rewards and 2 important warning signs

If these three stocks caught your attention, they are just a small sample of the ideas coming out of the Defensive Dividend Stocks screener, which currently surfaces 25 more companies with similarly compelling income and balance sheet stories through the Defensive Dividend Stocks screener. Use Simply Wall St to identify and analyze the specific catalysts, dividend profiles, and financial health narratives that matter most to you so you can focus on opportunities where you have the highest conviction.

Take Control of Your Investment Journey

If Convatec Group or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point.
Once you’ve made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.
Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.
By uncovering hidden catalysts and risks early, you’ll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Everyone Else?

Fresh ideas move first, and by the time the crowd catches on, the best entry points might already be flying past. Scan these curated lists now and look for opportunities early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com